Hepatitis B surface antigen-negative, but HBV DNA-positive patients in Bangladesh

Bangladesh Medical Research Council Bulletin

Volumn 38, Issue 3, 2012, Pages 104-107

  Mahtab, M A ^a   Akbar, S M F ^b   Rahman, S ^a  

^a BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

^b Shinagawa ku   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BANGLADESH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; SEROLOGY; VIRUS DETECTION;

EID: 84876935796     PISSN: 03779238     EISSN: None     Source Type: Journal    
DOI: 10.3329/bmrcb.v38i3.14337     Document Type: Article

References (16)

1. Ganem D, Prince AM. Hepatitis B virus infectionnatural history and clinical consequences. N Engl J Med 2004; 350: 1118-29.
2. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008; 48: 335-52
3. Liang TJ. Hepatitis B: the virus and the disease. Hepatology 2009; 49: S13-S21.
4. Tsui JI, French AL, Seaberg EC et al. Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women. Clin Infect Dis 2007; 45:736-40.
5. Sagnelli E, Imparato M, Coppola N et al. Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study. J Med Virol. 2008; 80: 1547-53.
6. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Bréchot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology. 2001; 34: 194-203.
7. Yuan Q, Ou SH, Chen CR et al. Molecular Characteristics of Occult Hepatitis B virus from blood donors in the southeast China. J Clin Microbiol. 2010; 48: 357-62.
8. Chemin I, Trépo C. Clinical impact of occult HBV infections. J Clin Virol. 2005; 34 Suppl 1:S15-21.
9. Raimondo G, Pollicino T, Squadrito G. What is the clinical impact of occult hepatitis B virus infection? Lancet. 2005 Feb 19-25; 365: 638-40
10. Lok AS, Liang RH, Chiu EK et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100: 182-8.
11. Hui CK, Cheung WW, Zhang HY et al. Kinetics and risk of de novo hepatitis B infection in HBsAgnegative patients undergoing cytotoxic chemotherapy. Gastroenterology. 2006;131:59-68.
12. Mindikoglu AL, Regev A, Schiff ER. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention. Clin Gastroenterol Hepatol. 2006; 4: 1076-81.
13. Mahtab MA, Rahman S, Karim MF et al. Epidemiology of hepatitis B virus in Bangladeshi general population. Hepatobiliary Pancreat Dis Int. 2008; 7:595-600.
14. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
15. Sugitani M, Sheikh A, Suzuki K et al. Seroepidemiology of sporadic acute hepatitis in Bangladesh: high prevalences of infection with type-B, type-E and multiple types of hepatitis virus. Ann Trop Med Parasitol. 2009; 103: 343-50.
16. Mahtab MA, Rahman S, Khan M, Mamun AA, Afroz S. Etiology of fulminant hepatic failure: experience from a tertiary hospital in Bangladesh. Hepatobiliary Pancreat Dis Int. 2008; 7: 161-4.